Cargando…

A Cost-Utility Analysis of SQ(®) Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective

BACKGROUND AND AIMS: Allergic rhinitis (AR) is an immunoglobulin E antibody-mediated inflammatory condition that arises in response to inhaled allergens such as pollen. Pollens from trees in the birch homologous group are the most common allergenic tree pollens in Northern and Central Europe and Nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollock, Richard F, Slættanes, Andreas K, Brandi, Henrik, Grand, Tobias Sydendal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904213/ https://www.ncbi.nlm.nih.gov/pubmed/36761408 http://dx.doi.org/10.2147/CEOR.S377399

Ejemplares similares

ITULAZAX(®) versus Alutard SQ(®) in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective
por: Rønborg, Steen M., et al.
Publicado: (2022)

Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
por: Vogelberg, Christian, et al.
Publicado: (2019)

Cost-effectiveness of SQ(®) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany
por: Green, William, et al.
Publicado: (2017)

Simplified AIT for allergy to several tree pollens—Arguments from the immune outcome analyses following treatment with SQ tree SLIT‐tablet
por: Würtzen, Peter Adler, et al.
Publicado: (2020)

The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study
por: Demoly, Pascal, et al.
Publicado: (2022)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
por: Hahn-Pedersen, J., et al.
Publicado: (2016)

5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen
por: van Nunen, Sheryl A., et al.
Publicado: (2022)

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT‐birch pollen extract for the treatment of allergic rhinitis: results of a phase II study
por: Pfaar, O., et al.
Publicado: (2015)

A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax(®)) in House Dust Mite Allergic Rhinitis With or Without Asthma
por: Sidenius, Kirsten, et al.
Publicado: (2021)

Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma
por: Kämpe, Mary, et al.
Publicado: (2007)

Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
por: Ellis, Anne K., et al.
Publicado: (2021)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Exposure to grass pollen – but not birch pollen – affects lung function in Swedish children
por: Gruzieva, O., et al.
Publicado: (2015)

Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season
por: Gherasim, Alina, et al.
Publicado: (2023)

Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
por: Tankersley, Mike, et al.
Publicado: (2021)

Different Development Forms of Local Allergic Rhinitis towards Birch
por: Bozek, Andrzej, et al.
Publicado: (2020)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
por: Ahlbeck, Lars, et al.
Publicado: (2022)

The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals
por: Smole, Ursula, et al.
Publicado: (2015)

Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults
por: Ruggeri, Matteo, et al.
Publicado: (2013)

29 Allergic Rhinitis to Ragweed Pollen
por: Bocsan, Ioana Corina, et al.
Publicado: (2012)

An assessment of cross reactivity with patients allergic to birch pollen using the immunoblotting
por: Zbikowska-Gotz, Magdalena, et al.
Publicado: (2011)

Anaphylaxis to topical Aloe vera in a birch pollen allergic child
por: Varga, Eva-Maria, et al.
Publicado: (2014)

Cross-Reactivity between Oak and Birch Pollens in Korean Tree Pollinosis
por: Jeong, Kyoung Yong, et al.
Publicado: (2016)

Comparative proteomics of common allergenic tree pollens of birch, alder, and hazel
por: Darnhofer, Barbara, et al.
Publicado: (2021)

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

Intestinal allergic inflammation in birch pollen allergic patients in relation to pollen season, IgE sensitization profile and gastrointestinal symptoms
por: Rentzos, Georgios, et al.
Publicado: (2014)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
por: Massaro, Ilaria, et al.
Publicado: (2017)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Ongoing seasonal intestinal inflammation in birch pollen allergic patients without gastrointestinal symptoms
por: Rentzos, Georgios, et al.
Publicado: (2011)

The Incidence of Delayed-Type Hypersensitivity Reactions to Apples Among Patients Allergic to Birch Pollen
por: Wagner, Aneta, et al.
Publicado: (2018)

Regional Difference of Causative Pollen in Children with Allergic Rhinitis
por: Sung, Myongsoon, et al.
Publicado: (2017)

Urban Tree Canopy and Asthma, Wheeze, Rhinitis, and Allergic Sensitization to Tree Pollen in a New York City Birth Cohort
por: Lovasi, Gina S., et al.
Publicado: (2013)

Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen
por: Ishida, Waka, et al.
Publicado: (2021)

Birch pollen—The unpleasant herald of spring
por: Raith, Marianne, et al.
Publicado: (2023)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

Bet v 1 triggers antiviral‐type immune signalling in birch‐pollen‐allergic individuals
por: Wisgrill, Lukas, et al.
Publicado: (2022)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b3ida0c0ulculbvlk4b9laal8m